InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2023-01-13 00:00:00 ET · period of report 2023-01-13 · accession 0001225208-23-000630 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-01-13 2023-01-13 EW MUSSALLEM MICHAEL A COB, CEO, Dir M - OptEx $35.20 +29.4K 186.7K +19% +$1.03M
D 2023-01-13 2023-01-13 EW MUSSALLEM MICHAEL A COB, CEO, Dir S - Sale+OE $78.09 -19.9K 157.4K -11% -$1.55M
DI 2023-01-13 2023-01-13 EW MUSSALLEM MICHAEL A COB, CEO, Dir G - Gift $0.00 +9,500 3.48M +0.3% $0
D 2023-01-13 2023-01-13 EW MUSSALLEM MICHAEL A COB, CEO, Dir G - Gift $0.00 -9,500 177.2K -5% $0
D 2023-01-13 2023-01-13 EW MUSSALLEM MICHAEL A COB, CEO, Dir M - OptEx $0.00 -29.4K 117.5K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-01-13 M A 29,375 $35.20 186,727.82 D By Living Trust — —
2 Common Common Stock 2023-01-13 S D 19,875 $78.09 157,352.82 D — — (F2) This transaction was executed in multiple trades at prices ranging from $77.43 to $78.40 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2023-01-13 G A 9,500 $0.00 3,482,517 I — —
4 Common Common Stock 2023-01-13 G D 9,500 $0.00 177,227.82 D — —
5 Derivative Employee Stock Option (Right to Acquire) 2023-01-13 M D 29,375 $0.00 117,500 D $35.20 · 2016-06-12 to 2023-05-11 29,375 Common Stock